The clinical lab underwent fire testing in 2020, where total tests represented 245% of baseline volumes, of which ~ 55% were molecular tests for SARS-CoV-2.I According to the CDC, about 41% of American adults delayed or avoided medical careii. Despite vaccines, many industry players suggest that SARS-CoV-2 test volumes will not be affected in the short term, and that demand for COVID-19-related testing will continue through 2021 and potentially. until 2022.iii. This means that volume pressure testing on the labs will continue.
Laboratories of all sizes face the same challenges: shortage of laboratory technologists and techniciansiv, historical financial pressures on hospitals and healthcare systemsvand laboratory professionals who are physically and mentally exhaustedvi – a pre-pandemic problem which has since worsened. However, TLA solutions that cater to laboratories handling high sample volumes are out of reach for smaller volume laboratories due to space requirements and infrastructure constraints.
The right Adjust for medium-sized laboratories
“When we look at the automation of our labs, it’s a balance between system throughput capability, test menu, and system footprint,” said Afruj Ruf, Managing Director of Integrated Pathology Solutions LLP, Airedale NHS Foundation Trust. “At the Harrogate District Hospital site, we knew that a large automated system would be too large and excessive and that a stand-alone system wouldn’t give us the streamlined workflow we wanted. What we needed was a compact automation system that would reduce the number of steps, require minimal human intervention and generated a valid first pass result so that our lab professionals do not move the samples but perform the scientific tasks. valuable for which they are trained. From its compact footprint and 80% manual labor minimization, to the smart routing that ensures our acute patients get their results faster than routine ones, the DxA 5000 Fit was just what we needed. “
In a survey, laboratory directors and managers were asked to identify the main challenges hospital laboratories face. Results revealed that staffing (26%) and turnaround times (23%) were identified as the top prioritiesvii. Automation plays a key role in helping to solve many of these problems while allowing precious resources to focus on high-value clinical tasks – this has been shown to be especially true during the COVID-19 pandemic.viii.
“For large labs, TLA is a reality today. However, for mid-volume labs like ours that process less than 4,000 tests per day, complete workflow automation solutions are not a big deal. option “, said Susan enciso, Chemistry System Supervisor, Excela Health. “Beckman Coulter’s DxA 5000 Fit solution is the perfect fit for us. It has a flexible design which is important in a lab like ours where space is at a premium; and reduces our manual process steps by up to 80%, helping us meet the unprecedented need for COVID-19 and routine testing. “
With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger labs:
- Complete automation of the workflow to reduce manual steps by up to 80% through pre-analytical, analytical and post-analytical automationix, retaining valuable human resources to perform higher-value clinical work
- Intelligent routing with dynamically calculated route planning for fast and consistent TAT, with STAT always prioritized to deliver results faster
- Flexible design which can be adapted to meet the space and infrastructure constraints of a medium-volume laboratory
“We chose the DxA 5000 Fit because it gives us end-to-end automation and will automate much of the routine pre and post-analytical work that our skilled technologists spend their time doing,” said Dr Hervé Vermeulen, laboratory director at Calais Hospital Center. “We look forward to lower, more consistent TATs and significant efficiency gains from the industry’s most comprehensive pre-analytical sample quality assessment, combined with automated pre-sample processing. analytical and connected chemistry and immunoassay analyzers.
The DxA 5000 Fit is authorized for sale in United States and most of European and Asian countries.
“At Beckman Coulter, we believe mid-sized labs should be able to leverage the benefits of automation to meet their challenges. Just because your lab isn’t processing more samples doesn’t mean you have to sacrifice the benefits of intelligent lab automation and go for a more automated work cell solution, “said Dr. Peter Soltani, senior vice president and general manager, hematology, urinalysis and workflow IT solutions at Beckman Coulter. “That’s why we launched DxA 5000 Fit, the first compact workflow automation solution that fits. adjust for medium-volume laboratories, because automation should concern all laboratories. “
Learn more about the Beckman Coulter family of automation solutions and the DxA 5000 Fit on our website at www.beckmancoulter.com/automation.
You can access the Multimedia Package for DxA 5000 Fit, which contains product videos, articles and other resources at www.beckmancoulter.com/DxA5000Fit-Media.
About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to strengthen the role of the diagnostic laboratory in improving patient outcomes. health care. Our diagnostic systems are used in complex biomedical tests and are found in hospitals, reference laboratories and physician offices around the world. Beckman Coulter offers a unique combination of people, processes and solutions designed to improve the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefits of automation to everyone, delivering better insights through clinical informatics, and unlocking hidden value through a performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is based in Brea, California., and has over 11,000 associates around the world who work diligently to make the world a healthier place.
© 2021 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in United States and other countries. 2021-8868
i Bonislawski, A. “The Clinical Laboratory in 2020: The Impact of COVID-19 This Year and Beyond.” 360 Dx. December 29, 2020. https://www.360dx.com/clinical-lab-management/clinical-lab-2020-impact-covid-19-year-and-beyond [Accessed: March 1, 2021]
ii Czeisler MÉ, Marynak K, Clarke KE et al. Delay or avoidance of medical care due to COVID-19 issues – United States, June 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1250-1257. DOI: http://dx.doi.org/10.15585/mmwr.mm6936a4.
iii Bonislawski, A. “How Will Laboratories Use Expanded Molecular Testing Capabilities After COVID-19?” 360 Dx. December 20, 2020. https://www.360dx.com/clinical-lab-management/how-will-labs-use-expanded-molecular-testing-capacities-post-covid-19 [Accessed: January 28, 2021]
iv Ford BA and McElavania E. “Machine Learning Takes Laboratory Automation to the Next Level”. Journal of Clinical Microbiology. March 2020, 58 (4) e00012-20; DOI: 10.1128 / JCM.00012-20
v Hospitals and health systems are facing unprecedented financial pressures from COVID-19. May 2020. Association of American Hospitals. https://www.aha.org/guidesreports/2020-05-05-hospitals-and-health-systems-face-unprecedented-financial-pressures-due [Accessed: March 1, 2021]
vi https://cbsaustin.com/news/local/medical-laboratory-professionals-perform-covid-19-tests-face-burnout-and-exhaustion [Accessed: March 1, 2021]
vii Report on the state of preparedness of the national health system for crises, edition 2020. Accumen. August 27, 2020. https://ACCUMEN.com/crisis-report-2020 [Accessed October 6, 2020]
viii Gramz, J. “The Benefits of Laboratory Automation to Facilitate Testing for SARS-CoV-2.” November 19, 2020. https://www.mlo-online.com/continuing-education/article/21163060/the-benefits-of-lab-automation-to-facilitate-testing-for-sarscov2 [Accessed: March 1, 2021]
ix Based on Beckman Coulter analysis of typical clinical diagnostic laboratory workflow steps. The number of steps may vary.
SOURCE Beckman Coulter Diagnostics